Skip to content

Study on Adhesion Properties of Three Different Adhesives

A Single Centre Comparison Study on Adhesion Properties of Three (3) Skin Adhesives on Healthy, Female, Adult Volunteers

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04125797
Enrollment
39
Registered
2019-10-14
Start date
2019-10-07
Completion date
2019-10-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This clinical investigation is a single centre, double blinded, case control study in healthy adult females. This study will be conducted in private rooms at Gentofte Hospital (Hjerte-medicinsk Forskning, post 835, Kildegårdsvej 28, 2900 Hellerup). The investigation centre will enroll 39 subjects including a 20% drop out within a four (4) months period. The subject will not be enrolled before approval of investigation protocol by the local ethics committee. The subjects need to meet the inclusion and exclusion criteria to be included in this clinical investigation. Each volunteer enrolled in the investigation can only participate once in a procedure. The testing period for each subject will be minimum 72 hours. The principal investigator's qualifications will be verified through his/her CV. The principal investigator is required to be a medical doctor with at least one year's experience in using similar medical adhesives (e.g. by being experienced in using electrodes where medical adhesives are included) and at least one year's experience with clinical research. In addition, the investigator must be trained in GCP before the study is initiated. If any subject withdraws from the study, they will not be replaced as drop-out rate is included in the sample size. Subjects must show up for two sessions, in the first session six adhesives will be placed below the subjects bra. The adhesives will be removed after minimum 72 hours at the second visit. While wearing the adhesives the subjects must keep the investigational area dry. 24, 48 and 72 hours after placement of the adhesives, the subject is asked to completed a questionnaire. The eCRF must be completed for each subject that has signed the Informed consent form (ICF) and enrolled into this clinical investigation.

Interventions

OTHERApplication of adhesive

Adhesive will be placed on the subjects skin on the trunk. Placement of the adhesive will be randomized.

Sponsors

Ambu A/S
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

The one arm tested three adhesives in parallel in random positions on the trunk. Investigator and participants were however blinded to the randomization placement.

Intervention model description

Each study participant will test two patches of each of three different experimental adhesives. Six patches in total. One set of each adhesive will be placed on the right side of the trunk while another set will be placed on the left side of the trunk. The position of the three adhesives on each side are randomly allocated.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Female Healthy Volunteers. * Age 18 - 40 years old. * Willing to attend two scheduled visits * Able to assess itch and adherence at 24h, 48h and 72h. * Provide written informed consent.

Exclusion criteria

* Non-intact skin barrier (e.g. eczema, rash, cut, scar tissue, wound, etc.). * History of inflammatory skin diseases (e.g. atopic dermatitis or psoriasis). * History of contact allergy * Swimming or engaging in sport activities causing sweat during study peri-od. v. Use of medication (e.g. corticosteroids) which could affect skin reactions.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Achieved Adhesion Success After 72 HoursAfter a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctorDid the adhesive stay attached to the skin for 72 hours (Yes/No). For the adhesive to be considered attached (yes) more than 75% adherence should be achieved. Rate of adhesion on a 5-point scale (no lift off the skin to detached and completely off the skin) 0 = ≥90% adhered (essentially no lift off the skin). 1. = ≥75% to \<90% adhered (only some edges lift off the skin). 2. = ≥50% to \<75% adhered (less than half lifts off the skin). 3. = \>0% to \< 50% adhered (more than half lifts off the skin without falling off). 4. = 0% adhered (detached and is completely off the skin). A worst-case scenario was used, i.e. the least favourable, score of the two scores (there are two scores as there are two adhesives of each type on every subject) for each type of adhesive.

Secondary

MeasureTime frameDescription
Number of Participants Experiencing Itchiness by the Adhesive at 24, 48 and 72 Hours24, 48 and 72 hours after adhesive applicationSubject evaluation of itchiness caused by the adhesives at 24, 48, 72 hours measured on visual analogue scale (VAS) (0-10) 0 = 'No itch', 10 = Worst imaginable itch. Adhesives when only including the worst score on each adhesive for each subject
Rate of Ease of Removal of Adhesive After 72 HoursAfter a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctorEase of removal on 5-point scale (very difficult to very easy) ; 1: Very difficult; 2: Difficult; 3: Acceptable; 4: Easy; 5: Very easy.
Rate of Pain During Removal of Adhesive After 72 HoursAfter a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctorSubject evaluation of pain during removal of the adhesives measured on visual analogue scale (0-10). 0= no pain, 10 = Worst possible pain
Rate of Skin Reaction After Wearing Adhesive for 72 HoursAfter a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctorSkin reaction rated on a scale from 0-7 (no evidence of irritation to strong reaction spreading beyond the application site). 0: No evidence of irritation 1. Minimal erythema that is barely perceptible 2. Definite erythema that is readily visible and minimal edema or minimal papular response 3. Erythema and papules 4. Definite edema 5. Erythema, edema and papules 6. Vesicular eruption 7. Strong reaction spreading beyond the application site
Number of Participants With Adhesive Residue Left on Skin After Removal of AdhesiveAfter a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctorThe number of participants with any adhesive residue left on skin after removal of adhesive (yes/no) after 72 hours.

Countries

Denmark

Participant flow

Pre-assignment details

This clinical investigation was a single centre, double blinded, case control study in healthy adult females. The investigation centre enrolled 39 subjects within one month. The three (3) types adhesive were randomly placed on subject's trunk. Each study participant will test two patches of each of three different experimental adhesives. Six patches in total. One set of each adhesive will be placed on the right side of the trunk while another set will be placed on the left side of the trunk.

Baseline characteristics

Characteristic
Age, Customized
Age
24.16 Years
STANDARD_DEVIATION 2.9
Sex: Female, Male
Female
38 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 38
other
Total, other adverse events
1 / 38
serious
Total, serious adverse events
0 / 38

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026